Annuncio pubblicitario
Italia markets close in 7 hours 43 minutes

  • FTSE MIB

    34.131,83
    +192,08 (+0,57%)
     

  • Dow Jones

    38.085,80
    -375,12 (-0,98%)
     

  • Nasdaq

    15.611,76
    -100,99 (-0,64%)
     

  • Nikkei 225

    37.934,76
    +306,28 (+0,81%)
     

  • Petrolio

    84,05
    +0,48 (+0,57%)
     

  • Bitcoin EUR

    59.964,70
    +397,00 (+0,67%)
     

  • CMC Crypto 200

    1.391,10
    -5,43 (-0,39%)
     

  • Oro

    2.356,40
    +13,90 (+0,59%)
     

  • EUR/USD

    1,0730
    -0,0003 (-0,03%)
     

  • S&P 500

    5.048,42
    -23,21 (-0,46%)
     

  • HANG SENG

    17.632,83
    +348,29 (+2,02%)
     

  • Euro Stoxx 50

    4.964,21
    +25,20 (+0,51%)
     

  • EUR/GBP

    0,8579
    +0,0005 (+0,06%)
     

  • EUR/CHF

    0,9781
    -0,0004 (-0,04%)
     

  • EUR/CAD

    1,4642
    -0,0007 (-0,05%)
     

Intra-cellular Therapies Inc (ITCI) Chairman, President & CEO Sharon Mates Sold $1. ...

GuruFocus.com
·2 minuto per la lettura

- By insider

Chairman, President & CEO of Intra-cellular Therapies Inc (30-Year Financial, Insider Trades) Sharon Mates (insider trades) sold 27,847 shares of ITCI on 02/19/2021 at an average price of $39.23 a share. The total sale was $1.1 million.


Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders. Intra-Cellular Therapies Inc has a market cap of $2.87 billion; its shares were traded at around $35.860000 with and P/S ratio of 234.38. GuruFocus has detected 4 severe warning signs with Intra-Cellular Therapies Inc. .

ANNUNCIO PUBBLICITARIO

CEO Recent Trades:

  • Chairman, President & CEO Sharon Mates sold 27,847 shares of ITCI stock on 02/19/2021 at the average price of $39.23. The price of the stock has decreased by 8.59% since.

CFO Recent Trades:

  • SVP of Finance CFO Lawrence J. Hineline sold 10,442 shares of ITCI stock on 02/19/2021 at the average price of $39.23. The price of the stock has decreased by 8.59% since.

Directors and Officers Recent Trades:

  • Chief Medical Officer Suresh K. Durgam sold 2,734 shares of ITCI stock on 02/19/2021 at the average price of $39.25. The price of the stock has decreased by 8.64% since.

  • EVP, Chief Commercial Officer Mark Neumann sold 5,184 shares of ITCI stock on 02/19/2021 at the average price of $39.22. The price of the stock has decreased by 8.57% since.

  • EVP and General Counsel Michael Halstead sold 11,139 shares of ITCI stock on 02/19/2021 at the average price of $39.24. The price of the stock has decreased by 8.61% since.

For the complete insider trading history of ITCI, click here

.This article first appeared on GuruFocus.